A large grant has been made to Iomai to further develop a technology to deliver flu vaccine by means of a disposable patch that includes an immune-system stimulating adjuvant. If the approach is successful, it might not only reduce immunization costs, but also allow less vaccine per immunisation. (Iomai is headquartered in Gaithersburg, Maryland, near where I live.)
The article also notes:
One intriguing possibility that Erck did not rule out is a partnership with MedImmune, the Gaithersburg company that makes the nasal-spray vaccine FluMist, the only needle-free flu vaccine.
Iomai is also reported to be in the last stages of development of patches that would prevent traveler's diarrhea.
No comments:
Post a Comment